Public pharma

Big Pharma keeps pushing for weaker pollution standards despite proven risks to human and environmental health

Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution

The WHO Executive Board will discuss global health priorities this week, including substandard and falsified medical products, with key implications for public pharmaceutical initiatives

Pharmacy services in Serbia have become entirely profit-driven, with the needs of the population pushed aside